ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021
Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020.
Abstract read
In one paragraph
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The association of intensity and duration of non-pharmacological interventions and implementation of vaccination with COVID-19 infection, death, and excess mortality: Natural experiment in 22 European countries.Journal of infection and public health · 2022Pooled it
- Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design.International journal of epidemiology · 2022Pooled it
- An adaptive method of emergency department syndromic surveillance to nowcast the frequency of presentations that will have a severe 28-day outcome following influenza or COVID-19 infection: a retrospective analytical record linkage study.American journal of epidemiology · 2026Article
- Excess mortality in Europe estimated by EuroMOMO during the COVID-19 pandemic and previous influenza seasons.Nature communications · 2026Article
- Spatial and demographic heterogeneity in excess mortality in the United States, 2020-2023: a multimodel approach.American journal of epidemiology · 2025Article
- Real-time monitoring of excess mortality under a new endemic regime.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Excess All-Cause Mortality by Age and Gender During the COVID-19 Pandemic in the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina: 2020-2022.Influenza and other respiratory viruses · 2025Article
- Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
- All-cause mortality and Japan's early countermeasures.Health science reports · 2024Article
- Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry.Scientific reports · 2023Article
- Social inequalities and long-term health impact of COVID-19 in Belgium: protocol of the HELICON population data linkage.BMJ open · 2023Article
- Article
- Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway.Vaccine · 2023Article
- Article
- Assessing COVID-19-Related Excess Mortality Using Multiple Approaches-Italy, 2020-2021.International journal of environmental research and public health · 2022Article
- Healthcare workers' heterogeneous mental-health responses to prolonging COVID-19 pandemic: a full year of monthly follow up in Finland.BMC psychiatry · 2022Article
- Excess all-cause mortality in the USA and Europe during the COVID-19 pandemic, 2020 and 2021.Scientific reports · 2022Observational
- Article
- One-year into COVID-19 pandemic: Decision-making and mental-health outcomes and their risk factors.Journal of affective disorders · 2022Article
- When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA.Langenbeck's archives of surgery · 2022Review
Corrections and comments
- Commented on by
Authors and funding
58 authors.
Sarah K NørgaardEuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.
Lasse S VestergaardEuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.
Jens NielsenEuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.
Lukas RichterAustrian Agency for Health and Food Safety, Vienna, Austria.
Daniela SchmidAustrian Agency for Health and Food Safety, Vienna, Austria.
Natalia BustosSciensano, Brussels, Belgium.
Toon BrayeSciensano, Brussels, Belgium.
Maria AthanasiadouMinistry of Health, Nicosia, Cyprus.
Theodore LytrasEuropean University Cyprus, Nicosia, Cyprus.
Gleb DenissovNational Institute for Health Development, Tallinn, Estonia.
Tatjana VeidemanNational Institute for Health Development, Tallinn, Estonia.
Oskari LuomalaFinnish National Institute for Health and Welfare, Helsinki, Finland.
Teemu MöttönenFinnish National Institute for Health and Welfare, Helsinki, Finland.
Anne FouilletFrench Public Health Agency (Santé Publique France), Saint-Maurice, France.
Céline Caserio-SchönemannFrench Public Health Agency (Santé Publique France), Saint-Maurice, France.
Matthias An der HeidenRobert Koch Institute, Berlin, Germany.
Helmut UphoffHessisches Landesprüfungs- und Untersuchungsamt im Gesundheitswesen, Dillenburg, Germany.
Kassiani GkolfinopoulouHellenic Centre for Disease Control and Prevention, Athens, Greece.
Janos BobvosNational Public Health Center, Budapest, Hungary.
Anna PaldyNational Public Health Center, Budapest, Hungary.
Naama RotemHealth & Vital Statistics Sector, Central Bureau of Statistics, Jerusalem, Israel.
Irene KornilenkoHealth & Vital Statistics Sector, Central Bureau of Statistics, Jerusalem, Israel.
Lisa DomeganHealth Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.
Joan O'DonnellHealth Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.
Francesca De DonatoDipartimento Epidemiologia del SSR, Lazio - ASL Roma 1, Rome, Italy.
Matteo ScortichiniDipartimento Epidemiologia del SSR, Lazio - ASL Roma 1, Rome, Italy.
Patrick HoffmannHealth Directorate Luxembourg - Division de l'inspection sanitaire, Luxembourg, Luxembourg.
Telma VelezHealth Directorate Luxembourg - Division de l'inspection sanitaire, Luxembourg, Luxembourg.
Kathleen EnglandDirectorate for Health Information and Research, Pieta, Malta.
Neville CallejaDirectorate for Health Information and Research, Pieta, Malta.
Liselotte van AstenNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Lenny StoeldraijerStatistics Netherlands, The Hague, the Netherlands.
Richard A WhiteNorwegian Institute of Public Health, Oslo, Norway.
Trine H PaulsenNorwegian Institute of Public Health, Oslo, Norway.
Susana P da SilvaInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
Ana P RodriguesInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
Petra KlepacNational Institute of Public Health, Ljubljana, Slovenia.
Metka ZaletelNational Institute of Public Health, Ljubljana, Slovenia.
Mario FafangelNational Institute of Public Health, Ljubljana, Slovenia.
Amparo LarrauriNational Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.
Inmaculada LeónNational Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.
Ahmed FarahPublic Health Agency of Sweden, Stockholm, Sweden.
Ilias GalanisPublic Health Agency of Sweden, Stockholm, Sweden.
Christoph JunkerFederal Statistical Office, Neuchâtel, Switzerland.
Damir PerisaFederal Office of Public Health, Bern, Switzerland.
Mary SinnathambyPublic Health England, Colindale, United Kingdom of Great Britain and Northern Ireland.
Nick AndrewsPublic Health England, Colindale, United Kingdom of Great Britain and Northern Ireland.
Mark G O'DohertyPublic Health Agency, Northern Ireland, United Kingdom of Great Britain and Northern Ireland.
David IrwinPublic Health Agency, Northern Ireland, United Kingdom of Great Britain and Northern Ireland.
Sharon KennedyPublic Health Scotland, Glasgow, United Kingdom of Great Britain and Northern Ireland.
Jim McMenaminPublic Health Scotland, Glasgow, United Kingdom of Great Britain and Northern Ireland.
Cornelia AdlhochEuropean Centre for Disease Prevention and Control, Solna, Sweden.
Nick BundleEuropean Centre for Disease Prevention and Control, Solna, Sweden.
Pasi PenttinenEuropean Centre for Disease Prevention and Control, Solna, Sweden.
Jukka PukkilaWorld Health Organization, Regional Office for Europe, Copenhagen, Denmark.
Richard PebodyWorld Health Organization, Regional Office for Europe, Copenhagen, Denmark.
Tyra G KrauseEuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.
Kåre MølbakEuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.
Funding
World Health Organization 001
Abstract
The European monitoring of excess mortality for public health action (EuroMOMO) network monitors weekly excess all-cause mortality in 27 European countries or subnational areas. During the first wave of the coronavirus disease (COVID-19) pandemic in Europe in spring 2020, several countries experienced extraordinarily high levels of excess mortality. Europe is currently seeing another upsurge in COVID-19 cases, and EuroMOMO is again witnessing a substantial excess all-cause mortality attributable to COVID-19.
Indexed as
AdolescentAdultAgedAged, 80 and overCause of DeathChildChild, PreschoolComputer SystemsCOVID-19Epidemiological MonitoringEuropeHumansInfantInfant, NewbornMiddle AgedMortalityall-cause mortalityCOVID-19 pandemicEuroMOMOEurope
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.